You are here

cutaneous T-cell lymphoma

FDA approves Citius' therapy for rare blood cancer

Reuters

Thu, 08/8/24 - 10:19 pm

Citius Pharmaceuticals

cutaneous T-cell lymphoma

Kymera receives FDA fast track designation for KT-333

Pharmaceutical Business Review

Tue, 09/19/23 - 10:42 am

Kymera Therapeutics

cutaneous T-cell lymphoma

FDA Rejects Soligenix's Lymphoma Candidate

BioSpace

Tue, 02/14/23 - 10:41 am

cutaneous T-cell lymphoma

Medivir delays pivotal HDAC trial as FDA discussions stall

Fierce Pharma

Mon, 06/18/18 - 09:58 pm

cutaneous T-cell lymphoma

Inching closer to blockbuster status, Seattle Genetics gets fourth FDA win for Adcetris

Endpoints

Fri, 11/10/17 - 11:26 am

Seattle Genetics

cutaneous T-cell lymphoma

FDA Grants Soligenix "Fast Track" Designation for SGX301 for the First-Line Treatment of Cutaneous T-Cell Lymphoma

Yahoo

Wed, 01/7/15 - 08:58 am

cutaneous T-cell lymphoma

Ceptaris wins FDA OK for lymphoma gel, clears path to $250M Actelion buyout

Fierce Biotech

Mon, 08/26/13 - 09:33 am

cutaneous T-cell lymphoma